[{"address1": "150 Baytech Drive", "city": "San Jose", "state": "CA", "zip": "95134", "country": "United States", "phone": "650 232 7200", "website": "https://www.procept-biorobotics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.", "fullTimeEmployees": 626, "auditRisk": 2, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 2, "previousClose": 60.14, "open": 60.14, "dayLow": 58.82, "dayHigh": 60.4, "regularMarketPreviousClose": 60.14, "regularMarketOpen": 60.14, "regularMarketDayLow": 58.82, "regularMarketDayHigh": 60.4, "beta": 1.04, "forwardPE": -40.214764, "volume": 852542, "regularMarketVolume": 852542, "averageVolume": 597635, "averageVolume10days": 583150, "averageDailyVolume10Day": 583150, "bid": 59.86, "ask": 60.06, "bidSize": 100, "askSize": 300, "marketCap": 3081337856, "fiftyTwoWeekLow": 24.83, "fiftyTwoWeekHigh": 77.0, "priceToSalesTrailing12Months": 19.710976, "fiftyDayAverage": 61.2864, "twoHundredDayAverage": 45.4942, "currency": "USD", "enterpriseValue": 2939060224, "profitMargins": -0.66125, "floatShares": 48868885, "sharesOutstanding": 51424200, "sharesShort": 4790717, "sharesShortPriorMonth": 5357470, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0932, "heldPercentInsiders": 0.04859, "heldPercentInstitutions": 0.83304, "shortRatio": 6.59, "shortPercentOfFloat": 0.1284, "impliedSharesOutstanding": 51424200, "bookValue": 5.138, "priceToBook": 11.662125, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -103370000, "trailingEps": -2.12, "forwardEps": -1.49, "pegRatio": -1.43, "enterpriseToRevenue": 18.801, "enterpriseToEbitda": -28.194, "52WeekChange": 0.76183474, "SandP52WeekChange": 0.26238096, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "PRCT", "underlyingSymbol": "PRCT", "shortName": "PROCEPT BioRobotics Corporation", "longName": "PROCEPT BioRobotics Corporation", "firstTradeDateEpochUtc": 1631712600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "49ad0be0-4fb2-3415-afa6-5f2d529da9da", "messageBoardId": "finmb_248398889", "gmtOffSetMilliseconds": -14400000, "currentPrice": 59.92, "targetHighPrice": 80.0, "targetLowPrice": 67.0, "targetMeanPrice": 74.0, "targetMedianPrice": 75.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 225576000, "totalCashPerShare": 4.387, "ebitda": -104244000, "totalDebt": 83301000, "quickRatio": 7.287, "currentRatio": 8.517, "totalRevenue": 156326000, "debtToEquity": 31.548, "revenuePerShare": 3.207, "returnOnAssets": -0.20312001, "returnOnEquity": -0.4729, "freeCashflow": -99360496, "operatingCashflow": -104361000, "revenueGrowth": 0.825, "grossMargins": 0.53473, "ebitdaMargins": -0.66683996, "operatingMargins": -0.62078, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]